Position in CAI
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$197,231
New position
Shares Held
11,068
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#171
of 246 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026GRANVILLE CAPITAL, INC. holds $197,231 across 1 Biotechnology name. CAI ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAI |
Caris Life Sciences, Inc.
This page
|
11,068 | $197,231 |
All Filings in CAI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $197,231 | 11,068 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||